Skip to main content
Exscientia logo

Exscientia

Updated Mar 24, 2026

Exscientia's full profile: funding, valuation, competitors, and the people behind the company.

🇬🇧United KingdomAcquiredAI Healthcare

Out of 100

🇬🇧

HQ

United Kingdom

🗓

Founded

2012

💰

Raised

$500M

🏷️

Stage

Acquired

👥

Team

100-500

Exscientia is an AI-driven drug design company that uses automated design-make-test-analyse cycles to generate drug candidates with the goal of reducing the time and cost of small molecule drug discovery. The Oxford-originated company builds generative chemistry models and automated laboratory robotics that together create a closed-loop system for molecular design, synthesis, and assay testing,

Is this your company? Claim it →

Key Facts

  • Exscientia has raised a total of $500M in disclosed funding across 1 funding rounds.
  • Exscientia was founded in 2012 by Andrew Hopkins and is headquartered in United Kingdom.
  • Exscientia employs approximately 100-500 people.
  • Exscientia operates in the AI Healthcare category and is currently at the Acquired stage.
  • Exscientia has an Awaira Score of 72/100, ranking it among the tracked AI companies on Awaira.
  • Exscientia's most recent funding round was a Series D of $225M closed in April 2021, led by SoftBank Vision Fund 2.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$500M

All rounds

72/100

2012

100-500 employees

Strengths

Strong Awaira Score of 72/100

Large team of 100-500+ employees

Established market presence (founded 2012)

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

⚠️ ESTIMATE
💵Est. Annual Revenue
$20M–$100M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does Exscientia stack up against competitors?

MetricExscientiaButterfly NetworkTempusAlan
Awaira Score72/10085/10084/10083/100
Total Raised$500M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageAcquiredPublicPublicSeries D
Founded2012201120152016
Employees100-500500-10002500500-1000
Country🇬🇧🇺🇸🇺🇸🇫🇷
A

Andrew Hopkins

Founder & CEO

View founder profile →
StageAcquired
Employees100-500
Country🇬🇧 United Kingdom
Connect
SoftBank Vision Fund 2Bristol-Myers Squibb
Inactive
1 round
Series DLatest

Led by SoftBank Vision Fund 2

$225M

Apr 2021

Frequently Asked Questions

What is Exscientia's valuation?
A confirmed valuation hasn't been made public. This is common for Acquired-stage companies in the AI Healthcare sector.
Who invested in Exscientia?
SoftBank Vision Fund 2, Bristol-Myers Squibb are among the backers. Together, they've contributed to the company's growth in the AI Healthcare sector.
When did Exscientia last raise funding?
The most recent round was a Series D of $225M, closed in April 2021. The round was led by SoftBank Vision Fund 2.
How many employees does Exscientia have?
The team is roughly 100-500 people, headquartered in United Kingdom.
What does Exscientia do?
Exscientia is an AI-driven drug design company that uses automated design-make-test-analyse cycles to generate drug candidates with the goal of reducing the time and cost of small molecule drug discovery. The Oxford-originated company builds generative chemistry models and automated laboratory robotics that together create a closed-loop system for molecular design, synthesis, and assay testing, producing candidates in months rather than the years required by conventional medicinal chemistry programmes. The company operates in the AI Healthcare sector from United Kingdom.
Who founded Exscientia?
The company was started by Andrew Hopkins in 2012 in United Kingdom. Andrew Hopkins serves as Founder & CEO.
Is Exscientia profitable?
Profitability data isn't available in public filings. The company has raised $500M in total funding and operates at the Acquired stage.
Where is Exscientia headquartered?
The headquarters sit in United Kingdom 🇬🇧 and was established in 2012. It competes in the AI Healthcare sector.
⚔️

Compare Exscientia

See how Exscientia stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →